EMEA-001881-PIP01-15
Key facts
| Active substance |
Ragweed pollen extract (Ambrosia artemisiifolia)
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0266/2016
|
| PIP number |
EMEA-001881-PIP01-15
|
| Pharmaceutical form(s) |
Oral lyophilisate
|
| Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
| Route(s) of administration |
Sublingual use
|
| Contact for public enquiries |
ALK Abelló A/S
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-001881-PIP01-15
|
| Compliance opinion date |
15/11/2019
|
| Compliance outcome |
positive
|